Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. (IRWD) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
irwd · stock forecast · 30 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 30 Wall Street analysts in the past 3 months
Hold
30 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.70
Consensus
$4.80
+45.9% upside
Low
$3.70
Median: $5 · Last Close: $3.29
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$4.80
45.9% upside
High Target
$5.7
73.3%
Low Target
$3.7
12.5%
Current Price
$3.29
as of today
Based on analyst price targets, the IRWD stock price prediction for the next 12 months ranges from $3.7 to $5.7. The consensus IRWD price forecast of $4.80 implies 45.9% upside from the current price of $3.29.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.13 | ↓ 5.00% |
1-day model range: $3.1–$3.15. Peak: $3.15 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -27.9% |
| 2028 | $2 | -38.9% |
| 2029 | $2 | -44.1% |
| 2030 | $2 | -46.6% |
| 2031 | — | -48.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IRWD · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-26 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-01-05 | Citizens | Upgrade ↑ | Market Perform→Market Outperform |
| 2026-01-05 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-11-11 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-04-15 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2025-04-15 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-04-14 | Leerink Partners | Maintains | Market Perform→Market Perform |
| 2025-01-30 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-01-22 | Craig-Hallum | Maintains | Buy→Buy |
| 2024-08-09 | Craig-Hallum | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ironwood Pharmaceuticals, Inc. (IRWD) stock. Of the recent 107 rating actions, 15 were upgrades and 19 were downgrades. 30 analysts currently cover IRWD.
Analyst Recommendation Trends
IRWD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$459M
↓ 6.0% YoY
Revenue Next Year
$478M
↑ 4.1% YoY
EPS This Year
$1.37
EPS Next Year
$1.40
↑ 2.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast IRWD EPS of $1.37 for the current fiscal year, based on estimates from 1 analysts. The IRWD revenue forecast is $459M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IRWD stock forecast is supported by two independent data sources: analyst consensus ratings from 30 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IRWD price target is $4.80 (+45.9% upside), with an analyst consensus of Hold.
The IRWD short-term stock prediction for tomorrow is $3.13 (-5.00%). The IRWD stock price prediction for 2027 estimates an average of $2. The IRWD stock prediction for 2030 projects a range of $2–$2.
Ironwood Pharmaceuticals, Inc. trades on NASDAQ under the ticker IRWD. The IRWD stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 37% of covering analysts.
Frequently asked questions
IRWD forecast · 8 questionsAccording to 30 Wall Street analysts, the average 12-month IRWD price target is $4.80, with a high forecast of $5.70 and a low of $3.70. The median price target is shown in the chart above when available. This implies +45.9% potential upside from the current price of $3.29.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.